Use of a Constitutively Active Hypoxia-Inducible Factor-1α Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients - Concepedia

Concepedia

Publication | Closed Access

Use of a Constitutively Active Hypoxia-Inducible Factor-1α Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients

183

Citations

20

References

2007

Year

Sanjay Rajagopalan, Jeffrey W. Olin, Steven R. Deitcher, Ann Pieczek, John R. Laird, Paul Grossman, Corey K. Goldman, Kevin McEllin, Ralph A. Kelly, Nicolas Chronos

Abstract

HIF-1alpha therapy in patients with critical limb ischemia was well tolerated, supporting further, larger, randomized efficacy trials.

References

	Year	Citations

Page 1